Skip to main content
. 2013 Aug 15;8(8):e70910. doi: 10.1371/journal.pone.0070910

Figure 11. CTA095 overcomes Src inhibitor resistance in prostate cancer cells.

Figure 11

PC3 and PC3-AZD20 (PC3 cell resistant to 20 μM AZD0530) cells were seeded at 2000 cells/well in 96 well plates overnight. The cells were treated with AZD0530 or CTA095 at the indicated concentrations. Cell viability was measured using MTT assay after 72 h. Symbols, mean; bars, standard deviation, n = 3.